These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 237551)

  • 1. Hydrolytic and transglucosylation activities of a purified calf spleen beta-glucosidase.
    Kanfer JN; Raghavan SS; Mumford RA
    Biochim Biophys Acta; 1975 May; 391(1):129-40. PubMed ID: 237551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beta-glucosidases of porcine kidney.
    Kanfer JN; Mumford RA; Raghavan SS
    Can J Biochem; 1977 Feb; 55(2):140-5. PubMed ID: 191159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathic Gaucher's disease with normal 4-methylumbelliferyl-beta-glucosidase activity in the liver.
    Owada M; Sakiyama T; Kitagawa T
    Pediatr Res; 1977 May; 11(5):641-6. PubMed ID: 870871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of activators and inhibitors to define the properties of the active site of normal and Gaucher disease lysosomal beta-glucosidase.
    Gatt S; Dinur T; Osiecki K; Desnick RJ; Grabowski GA
    Enzyme; 1985; 33(2):109-19. PubMed ID: 3924590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaucher's disease II. Studies on the kinetics of beta-glucosidase and the effects of sodium taurocholate in normal and Gaucher tissues.
    Choy FY; Davidson RG
    Pediatr Res; 1980 Jan; 14(1):54-9. PubMed ID: 6767218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acid beta-glucosidase and the diagnosis of Gaucher's disease in liver and spleen.
    Butterworth J; Broadhead DM
    Clin Chim Acta; 1978 Aug; 87(3):433-40. PubMed ID: 28186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrolytic and transglucolytic activities of a partially purified calf brain beta-glucosidase.
    Mumford RA; Raghavan SS; Kanfer JN
    J Neurochem; 1976 Oct; 27(4):943-8. PubMed ID: 184255
    [No Abstract]   [Full Text] [Related]  

  • 8. Purification and properties of a heat-stable glucocerebrosidase activating factor from control and Gaucher spleen.
    Peters SP; Coyle P; Coffee CJ; Glew RH
    J Biol Chem; 1977 Jan; 252(2):563-73. PubMed ID: 13071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Glucoside hydrolase activity of normal and glucosylceramidotic cultured human skin fibroblasts.
    Mueller OT; Rosenberg A
    J Biol Chem; 1977 Feb; 252(3):825-9. PubMed ID: 14134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sucrose gradient analysis of phospholipid-activated beta-glucosidase in type 1 and type 2 Gaucher's disease.
    Garrett KO; Prence EM; Glew RH
    Arch Biochem Biophys; 1985 Apr; 238(1):344-52. PubMed ID: 3920967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identity of 'acid' beta-glucosidase and glucocerebrosidase in human spleen.
    Ho MW
    Biochem J; 1973 Nov; 136(3):721-9. PubMed ID: 4780697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-specific differences in membrane beta-glucosidase from normal and Gaucher cells.
    Turner BM; Beratis NG; Hirschhorn K
    Biochim Biophys Acta; 1977 Feb; 480(2):442-9. PubMed ID: 13844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple forms of membrane-bound beta-glucosidase in Gaucher's disease.
    Yaqoob M; Carroll M
    Clin Genet; 1981 Aug; 20(2):161-7. PubMed ID: 6796311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of N-acyl phosphatidylethanolamines with different N-acyl groups as activators of glucocerebrosidase in various forms of Gaucher's disease.
    Basu A; Prence E; Garrett K; Glew RH; Ellingson JS
    Arch Biochem Biophys; 1985 Nov; 243(1):28-34. PubMed ID: 3933429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gaucher's disease: deficiency of 'acid' -glucosidase and reconstitution of enzyme activity in vitro.
    Ho MW; O'Brien JS
    Proc Natl Acad Sci U S A; 1971 Nov; 68(11):2810-3. PubMed ID: 5288260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease.
    Glew RH; Daniels LB; Clark LS; Hoyer SW
    J Neuropathol Exp Neurol; 1982 Nov; 41(6):630-41. PubMed ID: 6813430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of beta-glucocerebrosidase from beta-glucosidase in human tissues using sodium taurocholate.
    Peters SP; Coyle P; Glew RH
    Arch Biochem Biophys; 1976 Aug; 175(2):569-82. PubMed ID: 958319
    [No Abstract]   [Full Text] [Related]  

  • 18. A microassay for Gaucher's disease.
    Peters SP; Lee RE; Glew RH
    Clin Chim Acta; 1975 May; 60(3):391-6. PubMed ID: 806404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the activation of rat liver beta-glucosidase by sialosylgangliotetraosylceramide.
    Basu A; Glew RH
    J Biol Chem; 1985 Oct; 260(24):13067-73. PubMed ID: 3932339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The enzymatic hydrolysis of 6-acylamino-4-methylumbelliferyl-beta-D-glucosides: identification of a novel human acid beta-glucosidase.
    Mikhaylova M; Wiederschain G; Mikhaylov V; Aerts JM
    Biochim Biophys Acta; 1996 Oct; 1317(1):71-9. PubMed ID: 8876629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.